A mutation linked to retinitis pigmentosa in HPRP31 causes protein instability and impairs its interactions with spliceosomal snRNPs
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
19293337
DOI
10.1093/hmg/ddp125
PII: ddp125
Knihovny.cz E-resources
- MeSH
- Coiled Bodies genetics metabolism MeSH
- HeLa Cells MeSH
- Humans MeSH
- Mutation, Missense * MeSH
- Eye Proteins chemistry genetics metabolism MeSH
- Retinitis Pigmentosa genetics metabolism MeSH
- Ribonucleoproteins, Small Nuclear genetics metabolism MeSH
- Spliceosomes genetics metabolism MeSH
- Protein Stability MeSH
- Protein Binding MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Eye Proteins MeSH
- PRPF31 protein, human MeSH Browser
- Ribonucleoproteins, Small Nuclear MeSH
The AD29 mutation in HPRP31 belongs to a series of mutations that were initially linked with the autosomal dominant disorder retinitis pigmentosa (RP) type 11. The HPRP31 gene encodes the hPrp31 protein that specifically associates with spliceosomal small nuclear ribonucleoprotein particles (snRNPs). Despite intensive research, it is still unclear how the AD29 (Ala216Pro) mutation causes RP. In this study, we report that the expression of this mutant protein affects cell proliferation and alters the structure of nuclear Cajal bodies that are connected with snRNP metabolism. Interestingly, these effects can be reversed by the over-expression of the hPrp6 protein, a binding partner of hPrp31. Although Ala216 is not contained within the U4 or U5 snRNP interacting domains, we present several lines of evidence that demonstrate that the association between the AD29 mutant and snRNPs in the cell nucleus is significantly reduced. Finally, we show that the stability of the AD29 mutant is severely affected resulting in its rapid degradation. Taken together, our results indicate that the Ala216Pro mutation destabilizes the hPrp31 protein structure in turn reducing its interaction with snRNP binding partners and leading to its rapid degradation. These findings significantly impact our understanding of the molecular mechanisms underlying RP and suggest that the insufficiency of the functional hPrp31 protein combined with the potential cytotoxicity associated with the expression the AD29 mutant are at least partially causative of the RP phenotype.
References provided by Crossref.org
Retinitis pigmentosa-linked mutation in DHX38 modulates its splicing activity
DIS3L2 and LSm proteins are involved in the surveillance of Sm ring-deficient snRNAs
Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones
Mutations in spliceosomal proteins and retina degeneration
CRE promoter sites modulate alternative splicing via p300-mediated histone acetylation
Histone deacetylase activity modulates alternative splicing
The differential interaction of snRNPs with pre-mRNA reveals splicing kinetics in living cells